Carbamazepine is an anticonvulsant medication used primarily in the treatment of epilepsy and neuropathic pain. It is used in schizophrenia along with other medications and as a second-line agent in bipolar disorder
A Anant Labs fabrica e fornece impurezas de Carbamazepine de alta qualidade para o mercado global. Nossas impurezas EP de Carbamazepine são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
carbamazepine298-46-4Tegretol5H-Dibenz[b,f]azepine-5-carboxamideFinlepsinTegretalBistonCarbamazepenEquetroTelesminCarbazepineTimonilCarbamezepineKarbamazepinCarbatrolNeurotolStazepineEpitolCarbamazepinTegretol-XrTerilGeigy 32883CarbamazepinaCarbamazepinumCarnexivSirtalbenzo[b][1]benzazepine-11-carboxamide5-Carbamyl-5H-dibenzo(b,f)azepine5-Carbamoyl-5H-dibenzo(b,f)azepineG-328835H-Dibenz(b,f)azepine-5-carboxamideKarbelexNeurotopCarbamazepine Anhydrous5-Carbamoyl-5H-dibenz(b,f)azepineG 328835-Carbamoyl-5H-dibenz[b,f]azepineDTXSID4022731Carbamazepine extended releaseNSC-169864CHEBI:3387NSC16986433CM23913MDTXCID9027315-20-08-00247 (Beilstein Handbook Reference)Tegretol XRbenzo(b)(1)benzazepine-11-carboxamide2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamideEpimazCarbagen srEpimaz retSirtal retTegretol chewtabTeril retArbil mrCarbamazepine ER2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamideTimonil 200 retTimonil 400 retRefChem:5646Tegretol prolonged releaseN03AF015H-Dibenzo(b,f)azepin-5-carboxamide2-azatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide206-062-7Carbamat5H-Dibenzo[b,f]azepine-5-carboxamideLexinAmizepinBipotrolCalepsinMFCD00005073TrimonilNSC 169864CHEMBL1085-Carbamyldibenzo(b,f)azepineMLS0000696525-Carbamoyldibenzo(b,f)azepineCBZStazepindibenzo[b,f]azepine-5-carboxamides1693NCGC00015234-11CAS-298-46-4SMR0000582015H-dibenzo[b,f]azepine-5-carboxamide;Oxcarbazepine IMpurity ACarbelanTegretol CrCarbamazepinum [INN-Latin]Carbamazepina [INN-Spanish]SMR001227191HSDB 3019SR-01000000229Carbatrol extended-releaseEINECS 206-062-7BRN 1246090CarbmazepineNeurotop retardCarbamazepine?Carbagamma;Neurotop;Tegretol;Atretol;Carbium;Prozine;Timonil;Carbamazepine RSEpimaz;Epitol;Sirtal;UNII-33CM23913MCarba;Teril;Carbamazepine CRSTegretol (TN)N6WPrestwick_104Equetro (TN)Carbamazepine, powderOpera_ID_72Spectrum_000096Carbamazepine [USAN:USP:INN:BAN:JAN]Carbamazepine (Standard)Prestwick0_000052Prestwick1_000052Prestwick2_000052Prestwick3_000052Spectrum2_000125Spectrum3_000325Spectrum4_000262Spectrum5_000936Carbamazepine (Carbatrol)Lopac-C-4024ChemDiv1_018966CARBAMAZEPINE [MI]CBChromo1_000350Epitope ID:174842Iminostilbene-N-carboxamideCARBAMAZEPINE [INN]CARBAMAZEPINE [JAN]CARBAMAZEPINE [HSDB]CARBAMAZEPINE [USAN]Lopac0_000292Oprea1_790775SCHEMBL21639BSPBio_000203BSPBio_001929CARBAMAZEPINE [VANDF]KBioGR_000724KBioSS_000516MLS001055475MLS001074172MLS002548877BIDD:GT0479CARBAMAZEPINE [MART.]DivK1c_000388DivK1c_003750SPECTRUM1500159SPBio_000170SPBio_002124CARBAMAZEPINE [USP-RS]CARBAMAZEPINE [WHO-DD]CARBAMAZEPINE [WHO-IP]BPBio1_000225GTPL5339orb1310147orb3139395SCHEMBL29360181SCHEMBL29433237HMS501D10HMS640O02HY-B0246RKBio1_000388KBio2_000516KBio2_003084KBio2_005652KBio3_001149WLN: T C676 BNJ BVZCarbamazepine (JP18/USP/INN)CBZ;NSC 169864SPD-417Carbamazepine - Bio-X trade markCarbamazepine, analytical standardNINDS_000388Carbamazepine, 1mg/ml in MethanolGLXC-06091HMS1568K05HMS1920I17HMS2090M07HMS2091O19HMS2095K05HMS2233G16HMS3039K09HMS3259B21HMS3260L06HMS3372J13HMS3657G03HMS3712K05HMS3747E03HMS5079B14HMS6018K08Pharmakon1600-01500159CARBAMAZEPINE [ORANGE BOOK]HY-B0246MSK10039PXB902215-Carbomoyl-5H-dibenzo(b,f)azepineCARBAMAZEPINE [EP MONOGRAPH]CARBAMAZEPINE [USP IMPURITY]Tox21_110104Tox21_202273Tox21_300195Tox21_500292AC2074BBL005372BDBM50003659CARBAMAZEPINE [USP MONOGRAPH]CCG-38931EBC-11073NSC755920STK1773575H-Dibenz[b,f]azepine-5-carboxamineCarbamazepine 1.0 mg/ml in MethanolCARBAMAZEPINUM [WHO-IP LATIN]AKOS003235644AKOS025397243Tox21_110104_1AC-9538DB00564KS-5146LP00292NC00679NSC-755920SDCCGSBI-0050280.P005CDS1_002710IDI1_0003885H-Dibenzo[b,f]azepine-5-carboxamide #NCGC00015234-01NCGC00015234-02NCGC00015234-03NCGC00015234-04NCGC00015234-05NCGC00015234-06NCGC00015234-07NCGC00015234-08NCGC00015234-09NCGC00015234-10NCGC00015234-12NCGC00015234-13NCGC00015234-14NCGC00015234-15NCGC00015234-16NCGC00015234-18NCGC00015234-19NCGC00015234-33NCGC00023877-03NCGC00023877-04NCGC00023877-05NCGC00023877-06NCGC00023877-07NCGC00023877-08NCGC00253982-01NCGC00259822-01NCGC00260977-01BC166161ST075773SY002823Carbamazepine; Oxcarbazepine EP Impurity ASBI-0050280.P004DB-047659Dibenzo[b,f]azepine-5-carboxylic acid amideEU-0100292NS00000207Oxcarbazepine EP Impurity A (Carbamazepine)SW220141-1T0943EN300-21678OXCARBAZEPINE IMPURITY A [EP IMPURITY]BIM-0050280.0001C 4024C06868Carbamazepine, meets USP testing specificationsD002525H-Dibenz(b,f)azepine-5-carboxamide maleic acid5H-Dibenz(b,f)azepine-5-carboxamide oxalic acidAB00051931-17AB00051931-18AB00051931_19AB00051931_20F242225Q410412carbamazepine host structure with maleic acid removedcarbamazepine host structure with oxalic acid removedSR-01000000229-2SR-01000000229-4SR-01000000229-75H-Dibenz(b,f)azepine-5-carboxamide DL-tartaric acidBRD-K71799949-001-06-7BRD-K71799949-001-35-6BRD-K71799949-001-36-4F0348-2551Z104508594carbamazepine host structure with DL-tartaric acid removedDibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine)carbamazepine host structure with 4-hydroxybenzoic acid removedCarbamazepine, British Pharmacopoeia (BP) Reference StandardCarbamazepine, European Pharmacopoeia (EP) Reference StandardCarbamazepine, United States Pharmacopeia (USP) Reference Standard2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamideCarbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material